Showing results (81-90 of 384) with videos related to
Sort By:
Pageof 39
International Journal of Surgical Pathology|January 27, 2016
The Current Status of Solitary Fibrous Tumor: Diagnostic Features, Variants, and GeneticsKhin Thway, Wen Ng, Jonathan Noujaim, et al.Cancers|August 12, 2022
Inflammatory Myofibroblastic Tumour: State of the ArtLouis Gros, Angelo Paolo Dei Tos, Robin L Jones, et al.International Journal of Surgical Pathology|April 7, 2018
Endometrial Stromal Sarcoma With Hyalinizing Giant Rosettes, Mimicking Low-Grade Fibromyxoid SarcomaEva Kolson Kokohaare, Dirk C Strauss, Robin L Jones, et al.Sarcoma|October 16, 2020
Diagnostic Differences in Expert Second-Opinion Consultation Cases at a Tertiary Sarcoma CenterAsha Rupani, Magnus Hallin, Robin L Jones, et al.Current Opinion in Oncology|May 3, 2013
Diagnosis, prognosis, and management of leiomyosarcoma: recognition of anatomic variantsAndrew J Bathan, Anastasia Constantinidou, Seth M Pollack, et al.Future Oncology (London, England)|April 28, 2018
The current landscape of early drug development for patients with sarcoma in the immunotherapy eraAna Sebio, Breelyn A Wilky, Vicki L Keedy, et al.International Journal of Surgical Pathology|September 25, 2015
Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue TumorsJonathan Noujaim, Khin Thway, Amna Sheri, et al.Cancer Biology & Therapy|March 5, 2016
p.(L576P) -KIT mutation in GIST: Favorable prognosis and sensitive to imatinib?Jonathan Noujaim, David Gonzalez, Khin Thway, et al.Expert Opinion on Pharmacotherapy|June 16, 2023
Pharmacotherapeutic strategies for epithelioid sarcoma: are we any closer to a non-surgical cure?Magdalena Meissner, Andrea Napolitano, Khin Thway, et al.The Lancet. Oncology|June 26, 2007
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective studyFederica Grosso, Robin L Jones, George D Demetri, et al.Pageof 39